The present invention relates to medical imaging, and in particular to a hybrid medical imaging probe apparatus and process for imaging biological tissues of a subject.
Medical imaging technologies such as ultrasound, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear medicine imaging are extremely powerful techniques for imaging internal features of the human body, but suffer from a number of disadvantages that limit their applicability. For example, these technologies require expensive equipment, and are therefore not generally available at rural or remote health centres. Indeed, according to the World Health Organization (WHO), more than half of the world's population does not have access to diagnostic imaging. Furthermore, there is a general need for low-cost and safe imaging systems for the detection and continuous monitoring of a variety of diseases. Due to the need to limit exposure to ionising radiation such as X-rays, most currently available medical imaging systems cannot be used for frequent monitoring purposes. Additionally, the bulky and static structures and high costs of MRI and other large medical imaging systems often preclude them for monitoring diseases that require monitoring on a regular and short-term basis. These factors make such systems impractical to be used by paramedics for real-time imaging and assessment purposes.
Electromagnetic imaging is an attractive technique for medical applications, and has the potential to create a visual representation of the interior of the human body in a cost-effective and safe manner. From an electromagnetic engineering perspective, the human body is an electromagnetically heterogeneous medium characterized by features and tissues with different dielectric properties. Moreover, the dielectric properties permittivity and conductivity differ between injured and healthy tissues. When an injured tissue with a high permittivity value compared to its neighbouring healthy tissue is exposed to an electromagnetic wave at a microwave frequency, a relatively high portion of the wave is reflected back towards the radiation source. Accordingly, an electromagnetic medical imaging apparatus can be utilized to transmit electromagnetic waves into a body part to be imaged, such as the human head or torso. Microwave signals predominantly reflected by damaged tissues (e.g., in particular at bleeding or clot sites) due to changes in electromagnetic properties are received and measured by the apparatus. Then, the data representing the measured signals can be processed to estimate the location and/or dielectric properties of the abnormality, and to generate two or three-dimensional images of the damaged tissues within the body part.
The data processing step plays a critical role in an electromagnetic imaging apparatus. Various imaging techniques have been employed to detect medical targets from measurements of scattered electromagnetic signals. Those techniques try to estimate the dielectric properties of the tissues by solving nonlinear equations (tomography), which do not have a unique solution and those solutions might not depend continuously on the input data, or to find the location of target tissues using time-domain radar-based techniques. Due to the time-consuming nature of tomography-based techniques, they are almost exclusively applicable to single frequency or narrow-band multi-frequency signals, and therefore are not suitable for use in medical emergency situations such as brain injury detection, where a rapid diagnosis is required. Alternatively, in radar-based imaging, a scattering profile of the imaging domain is mapped onto a two- or three-dimensional image. This method is more applicable when using ultra-wide frequency bands for fine resolution because the required data processing is simpler and faster than tomography. However, current radar imaging methods, such as confocal, microwave imaging via space-time (“MIST”) beamforming, and adaptive beamforming imaging methods utilize processing techniques based on delay-and-sum (DAS), which are susceptible to outer layer reflections and internal layer refractions that can result in false detection. In addition, the variation of signal penetration through the tissues at different frequencies limits the effectiveness of those delay calculations, and consequently the accuracy of the resulting images. In view of these difficulties, there is a continuing need for a faster and accurate imaging apparatus and process.
It is desired to overcome or alleviate one or more difficulties of the prior art, or to at least provide a useful alternative.
In accordance with some embodiments of the present invention, there is provided a hybrid medical imaging probe for application to a body part to image tissues within the body part, the medical imaging probe including:
In some embodiments, the first imaging probe component is an ultrasonic imaging probe component. In some embodiments, the ultrasonic imaging probe component includes an ultrasonic transducer, and the electromagnetic imaging probe component includes an array of antennas disposed about the ultrasonic transducer.
In some embodiments, the antennas are loaded with series capacitance and/or shunt inductance to create resonances that are independent of the size of the antennas.
In some embodiments, the hybrid medical imaging probe includes electromagnetic bandgap (EBG) structures to reduce the mutual coupling between the antennas, thereby allowing the antennas to be located in close mutual proximity.
In some embodiments, the hybrid medical imaging probe includes artificial magnetic surfaces (AMS) such as metasurfaces formed by arrays of periodic structures and configured so that the array of antennas generate predominantly unidirectional radiation, thereby allowing the antennas to be located in close mutual proximity.
In some embodiments, the hybrid medical imaging probe includes metamaterial absorbers to reduce the leakage of microwave signals.
In accordance with some embodiments of the present invention, there is provided a hybrid medical imaging apparatus for imaging tissues within a body part, the medical imaging apparatus including:
In some embodiments, the data processing component is further configured to generate an image representing a spatial distribution of the permittivity of the tissues of the body part.
In accordance with some embodiments of the present invention, there is provided a hybrid medical imaging process for imaging tissues within a body part, the medical imaging process including the steps of:
In some embodiments, the hybrid medical imaging process includes generating a second image of the tissues of the body part, the second image representing a spatial distribution of the permittivity estimates.
In some embodiments, the first imaging technology is an ultrasonic imaging technology.
In some embodiments, the step of generating the electromagnetic model includes determining a distance between a region of interest within the body part and a corresponding surface of the body part, and an estimate of permittivity of the region of interest is generated by solving a system of equations modelling microwave propagation from the surface to the region of interest and from the region of interest back to the surface of the body part.
In some embodiments, the permittivity value is estimated from scattered microwave signals of a plurality of different microwave frequencies to improve the accuracy of the estimate.
In some embodiments, the tissues include an internal organ, and the process includes assessing a health status of the internal organ from the estimated permittivity value of the internal organ.
In some embodiments, assessing a health status of the internal organ includes estimating a percentage of fat in the internal organ. The internal organ may be a liver.
In some embodiments, the hybrid medical imaging process includes estimating respective permittivities of left and right sides of a patient's torso, and comparing those permittivities to assess a health status of the patient. In some embodiments, assessing a health status of the patient includes diagnosing whether the patient has a disease.
In accordance with some embodiments of the present invention, there is provided at least one computer-readable storage medium having stored thereon executable instructions that, when executed by at least one processor of a data processing apparatus, cause the at least one processor to execute any one of the above processes.
In accordance with some embodiments of the present invention, there is provided a hybrid medical imaging apparatus including:
Also described herein is a medical imaging probe for application to a body part to image tissues within the body part, the medical imaging probe including:
The real-time imaging probe may be an ultrasonic imaging probe. The ultrasonic imaging probe component may include an ultrasonic transducer, and the electromagnetic imaging probe component may include an array of antennas disposed about the ultrasonic transducer.
Also described herein is a medical imaging apparatus for imaging tissues within a body part, the medical imaging apparatus including:
Also described herein is a medical imaging process for imaging tissues within a body part, the medical imaging process including the steps of:
The real-time imaging technology may be ultrasonic imaging technology.
The step of generating the electromagnetic image may include determining a distance between a region of interest within the body part and a corresponding surface of the body part, and determining a permittivity value for the region of interest by solving a system of equations modelling microwave propagation from the surface to the region of interest and from the region of interest back to the surface of the body part.
Also described herein is a process for diagnosing organ disease in a patient, the process including:
Some embodiments of the present invention are hereinafter described, by way of example only, with reference to the accompanying drawings, wherein:
The inventors have identified that the accuracy, speed and reliability of medical electromagnetic imaging (“EM”) can be significantly improved by using a non-microwave first imaging technology to accurately determine the respective locations of one or more targeted tissues or internal organs of a subject (preferably, but not necessarily, in real-time), and then using those locations as a priori information to model microwave propagation to and from the internal organs/tissues and scattering by the internal organs/tissues in order to measure the complex permittivity of those organs/tissues. The permittivity of an internal organ such as the liver is a measure of its health, and can be used to diagnose certain conditions such as fatty liver disease, for example, as described below.
Additionally, the locations of inner organs (or other biological tissue(s) of interest) determined from the first imaging technology can be used to generate corresponding second images of those same tissues or organs using microwave imaging as a second imaging technology (different to the non-microwave first imaging technology), where the second images represent the corresponding spatial distributions of permittivity values.
For example, commercially available portable UltraSound (“US”)-machines provide detailed location information of internal tissues and organs using their embedded algorithms, resulting in images such as the one shown in
As shown in
Although the data processing component of the described embodiments is in the form of a computer with hybrid medical imaging processing components 302, 303 installed therein, this need not be the case in other embodiments. As shown in
The data processing component 208 includes random access memory (RAM) 306, at least one processor 308, and external interfaces 310, 312, 313, 314, all interconnected by a bus 316. The external interfaces include universal serial bus (USB) interfaces 310, at least one of which is connected to a keyboard 318 and a pointing device such as a mouse 319, and a display adapter 314, which is connected to a display device such as an LCD panel display 322. The first and second imaging component controllers 204, 206 are communicatively coupled to the data processing component 208 via the USB interfaces 310, allowing these controllers 204, 206 to control their respective probe sub-components.
The software components 302, 303 include a first imaging component 302 that receives imaging signals or data from the first imaging component controller 204, and generates corresponding first images 305 of the subject's tissues. Those first images 305 are then provided as a priori information to an EM processing component 303, which estimates dielectric properties of internal organs/tissues and optionally generates EM images 307 of those organs/tissues from the first images 303 and EM scattering data or signals received from the second (microwave) component controller 206, as described below.
In use, the hybrid electromagnetic-ultrasound (“HEUS”) imaging probe 202 is used to scan a region of interest (e.g., the head or torso) of the body of a subject/patient. As shown in
Depending on the requirements of the imaging algorithm, the targeted organ to be imaged and the type of images, either an antenna or an array of wideband antennas (as shown in
For example, in some embodiments, the antenna size is dramatically reduced by applying metamaterial loading in which the antenna is loaded with series capacitance and/or shunt inductance to create resonances that are independent of the size of the antenna, as described in S. Ahdi Rezaeieh, M. A. Antoniades and A. M. Abbosh, “Miniaturization of Planar Yagi Antennas Using Mu-Negative Metamaterial-Loaded Reflector,” IEEE Transactions on Antennas and Propagation, vol. 65, no. 12, pp. 6827-6837, December 2017.
In some embodiments, electromagnetic bandgap (EBG) structures are used to reduce mutual coupling by creating an electromagnetic bandgap that prevents the radiation of surface currents, as described in H. Nakano, K. Kikkawa, N. Kondo, Y. Iitsuka and J. Yamauchi, “Low-Profile Equiangular Spiral Antenna Backed by an EBG Reflector,” IEEE Transactions on Antennas and Propagation, vol. 57, no. 5, pp. 1309-1318, May 2009.
In some embodiments, the antennas include artificial magnetic surfaces (AMS) such as metasurfaces that are formed using arrays of periodic structures to generate unidirectional radiation, as described in A. Rezaeieh, M. A. Antoniades and A. M. Abbosh, “Compact and Unidirectional Resonance-Based Reflector Antenna for Wideband Electromagnetic Imaging,” IEEE Transactions on Antennas and Propagation, vol. 66, no. 11, pp. 5773-5782, November 2018. These surfaces generate zero reflection phase which allows the antennas to be located at close proximity to one another and also to the reflecting surface of the reflector disposed behind each of the antennas.
Finally, in some embodiments, the hybrid probe 202 includes metamaterial absorbers that dissipate the energy of the received signal from certain angles to reduce the leakage of electromagnetic signals from the hybrid probe 202, as required by hospitals.
In the described apparatus, the ultrasound probe component 502 and its corresponding controller 204 are used to provide the prior information regarding the location of the internal tissues or organ (e.g., the liver) of interest relative to the patient's skin. For example, to image the patient's liver, the antenna/antennas transmit microwave signals towards and into the patient's torso, and the reflected signals from each path/tissue are detected and data representing the detected signals sent by the microwave component controller 206 to the data processing component 208. A matching gel 214 can be used between the hybrid probe 202 and the patient's torso to facilitate the penetration of the signals into the patient's body and reduce surface reflections. The antenna and ultrasound signals are transmitted along respective cables by a common cable loom to the hybrid probe 202. The electromagnetic microwave signals are generated and recorded by the portable vector network analyser (VNA) 206. Both the portable VNA 206 and the US-controller 204 are communicatively coupled to the data processing component 208 using suitable data transfer interfaces, cables and protocols, being USB in the described embodiments. The data received from the ultrasound and microwave imaging component controllers 204, 206 are provided as inputs to the hybrid medical imaging process, as described below, and the electromagnetic permittivity and optionally an image of the region of interest is then generated.
In the described embodiments, the scanning domain is modelled as a multilayer dielectric slab which is illuminated by a plane wave normally incident from the or each antenna at z<0, as shown in
E
i(z)={circumflex over (x)}E0e−γm
where E0 is the wave amplitude and γm=jω√{square root over (με0{circumflex over (ε)}m)} is the propagation constant of the matching medium with complex dielectric permittivity of {circumflex over (ε)}m=ε′m−jε″m. The measured distance between the skin and the region of interest, for example the patient's liver d, is used to calculate the total electric field as a function of distance by the sum of traveling waves in each tissue region:
Boundary conditions at the interfaces require the continuity of electric and magnetic fields Et(z) and
which results in the following equations:
E
0
+E
1
=E
2
+E
3 (3)
E
0
−E
1
={circumflex over (n)}
21(E2−E3) (4)
E
2
e
−γ
d
+E
3
e
γ
d
=E
4 (5)
E
2
e
−γ
d
−E
3
e
γ
d
={circumflex over (n)}
32
E
4 (6)
where,
is the complex refractive index, and {circumflex over (ε)}p=ε′p−jε″p is the complex dielectric permittivity of the p-th tissue layer. The solution for the reflected wave is then
Therefore, the S-parameter measured by the or each antenna is estimated by:
In this equation, R32, which is a function of dielectric properties of the liver (in this example), is unknown. Knowing the thickness d and dielectric permittivity of the outer tissue layer {circumflex over (ε)}d, as well as the permittivity of the matching medium {circumflex over (ε)}m, the unknown parameter R32 is estimated by minimizing the error between the measured and calculated S-parameter, as follows:
Because the dielectric permittivity is a complex value, a multi-objective optimization technique (such as the one described in Kaisa Miettinen (1999), Nonlinear Multiobjective Optimization, Springer, ISBN 978-0-7923-8278-2) can be used to find a non-inferior (trade-off) solution for (11) which simultaneously minimises the real and imaginary parts of the error. Therefore, the complex permittivity of the liver {circumflex over (ε)}li is estimated by:
If the hybrid imaging probe 202 includes an array of antennas, the estimated S-parameters of each element from equation (10) are used to provide an estimation matrix that is used to find the effective permittivity of the liver via an optimization process. In the described embodiments, a distributed iterative optimization algorithm (such as those described in A. Falsone, K. Margellos and M. Prandini, “A Distributed Iterative Algorithm for Multi-Agent MILPs: Finite-Time Feasibility and Performance Characterization”, IEEE Control Systems Letters, vol. 2, no. 4, pp. 563-568, October 2018 and J. Tsitsiklis, D. Bertsekas and M. Athans, “Distributed asynchronous deterministic and stochastic gradient optimization algorithms”, in IEEE Transactions on Automatic Control, vol. 31, no. 9, pp. 803-812, September 1986) is used to minimise the estimation error and converge to the global solution for equation (11). The estimated value is then used in equation (12) to find the effective permittivity {circumflex over (ε)}i of the targeted organ, such as the liver.
In embodiments with wideband or multi-frequency antenna(s), different frequency steps can be used to generate more accurate estimates. In that case, the Debye function is used to model the dielectric permittivity of the targeted tissue according to:
where, εs is the permittivity at zero frequency, ε∞ is the permittivity at infinite frequency, and τ0 is the relaxation time. By substituting equation (13) in the refraction index formula and solving the optimization problem of equation (11) for the three constants εs, ε∞, and τ0, the dielectric properties of the organ, such as the liver, can be estimated as a function of frequency. In that regard, the signals should be sampled evenly and the number of frequency samples should be greater than six (twice the number of unknowns in the Debye function of equation (13)).
Knowing the values of the permittivity and conductivity of the healthy organ, such as the liver, across the used frequency band, the difference between the estimated permittivity of the scanned patient's organ, such as the liver, and the healthy organ can be interpreted to assess the healthy or unhealthy status of the organ, such as finding the percentage of fat in the liver for the case of fatty liver disease, for example.
In some embodiments, a horizontal cross-section of a patient's chest (torso) is scanned and virtually divided into two portions representing the “right side” and “left side” of the patient's torso so that the right side portion is mainly occupied by the patient's liver, whereas the left side portion of contains the patient's spleen, pancreas and kidney organs. In the microwave frequency band of 0.5-1 GHz, the dielectric properties of the organs on the left side have an average permittivity of 60, whereas the average permittivity of a healthy liver is about 48. Thus, there is about a 25% difference between the dielectric properties of the left and right-side organs in a healthy patient. Accordingly, the inventors have determined that, using the signal processing techniques described herein, the amplitude and phase of the back scattered microwave signals that are reflected or transmitted through these organs on the left and right side portions of the patient's torso can be used to determine the permittivity of the investigated organ. Then, these calculated values are used to define a threshold/range for healthy subjects. That is, if a person is healthy, then the reflected/transmitted signals from left and right sides exhibit a difference of around 25%. However, the average permittivity of fatty liver tissue is around 37, which increases the ratio of the signals for the left and right sides to about 62%, and there is more than 100% contrast between the permittivity of livers of healthy and unhealthy persons. Thus, these values can be used to diagnose and monitor fatty liver and similar diseases in the chest area.
Many modifications will be apparent to those skilled in the art without departing from the scope of the present invention.
Number | Date | Country | Kind |
---|---|---|---|
2019900842 | Mar 2019 | AU | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/AU2020/050242 | 3/13/2020 | WO | 00 |